EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia

• Sara Charmsaz ,

  * E-mail: Sara.Charmsaz@qimrberghofer.edu.au

  Affiliation QIMR Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Kirrilee Beckett,

  Affiliation QIMR Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Fiona M. Smith,

  Affiliation QIMR Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Claudia Bruedigam,

  Affiliation QIMR Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Andrew S. Moore,

  Affiliations The University of Queensland, Brisbane, Australia, Children’s Health Queensland Hospital and Health Service, Brisbane, Australia

  ⨯
• Fares Al-Ejeh,

  Affiliation QIMR Berghofer Medical Research Institute, Brisbane, Australia

  ⨯
• Steven W. Lane,

  Affiliations QIMR Berghofer Medical Research Institute, Brisbane, Australia, The University of Queensland, Brisbane, Australia

  ⨯
• Andrew W. Boyd

  Affiliations QIMR Berghofer Medical Research Institute, Brisbane, Australia, The University of Queensland, Brisbane, Australia

  ⨯